RECRUITING

Advancing Access to HIV/HCV Testing for People Who Inject Drugs (PWID)

Description

The purpose of this study is to test the effectiveness of the ACCESS strategy: an organizational-level intervention that uses funding and practice facilitation to improve the organizational capacity of syringe services programs (SSPs) to implement routine, opt-out HIV and Hepatitis C (HCV) testing and linkage to care for people who inject drugs (PWID).

Conditions

Study Overview

Study Details

Study overview

The purpose of this study is to test the effectiveness of the ACCESS strategy: an organizational-level intervention that uses funding and practice facilitation to improve the organizational capacity of syringe services programs (SSPs) to implement routine, opt-out HIV and Hepatitis C (HCV) testing and linkage to care for people who inject drugs (PWID).

Project ACCESS: Advancing Access to HIV/HCV Testing Through Transformation in Syringe Services Programs: A Cluster Randomized Trial

Advancing Access to HIV/HCV Testing for People Who Inject Drugs (PWID)

Condition
HIV Infections
Intervention / Treatment

-

Contacts and Locations

Miami

University of Miami, Miami, Florida, United States, 33136

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * SSPs must:
  • 1. be operating in an Ending the HIV Epidemic (EHE) or Centers for Disease Control and Prevention (CDC) determined vulnerable jurisdictions;
  • 2. serve at least 300 unique participants per year;
  • 3. not currently offer opt-out HIV/HCV testing;
  • 4. be capable and willing to prospectively collect aggregated, site-level data on the number of participants who are: i) offered HIV/HCV screening, ii) completed these tests, and iii) linked to care, as well as provide participant demographics;
  • 5. have key staff that consent to participate in study surveys, qualitative interviews and practice facilitation throughout the study.
  • * SSPs must not:
  • 1. currently receive or have received Frontline Communities in the United States (FOCUS) funding;
  • 2. have already implemented opt-out HIV/HCV testing.

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

Yes

Collaborators and Investigators

University of Miami,

Tyler Bartholomew, PhD, PRINCIPAL_INVESTIGATOR, University of Miami

Study Record Dates

2028-08-01